223 related articles for article (PubMed ID: 22021636)
21. Evidence that specific interactions play a role in the cholesterol sensitivity of G protein-coupled receptors.
Geiger J; Sexton R; Al-Sahouri Z; Lee MY; Chun E; Harikumar KG; Miller LJ; Beckstein O; Liu W
Biochim Biophys Acta Biomembr; 2021 Sep; 1863(9):183557. PubMed ID: 33444621
[TBL] [Abstract][Full Text] [Related]
22. Signaling through cholesterol esterification: a new pathway for the cholecystokinin 2 receptor involved in cell growth and invasion.
Paillasse MR; de Medina P; Amouroux G; Mhamdi L; Poirot M; Silvente-Poirot S
J Lipid Res; 2009 Nov; 50(11):2203-11. PubMed ID: 19502590
[TBL] [Abstract][Full Text] [Related]
23. Cholecystokinin modulates migration of gonadotropin-releasing hormone-1 neurons.
Giacobini P; Kopin AS; Beart PM; Mercer LD; Fasolo A; Wray S
J Neurosci; 2004 May; 24(20):4737-48. PubMed ID: 15152034
[TBL] [Abstract][Full Text] [Related]
24. Molecular mechanism underlying partial and full agonism mediated by the human cholecystokinin-1 receptor.
Archer-Lahlou E; Escrieut C; Clerc P; Martinez J; Moroder L; Logsdon C; Kopin A; Seva C; Dufresne M; Pradayrol L; Maigret B; Fourmy D
J Biol Chem; 2005 Mar; 280(11):10664-74. PubMed ID: 15632187
[TBL] [Abstract][Full Text] [Related]
25. Heterodimerization of cholecystokinin 1 and cholecystokinin 2 receptors in gallbladder cancer: a new mechanism for carcinogenesis.
Nigam J; Kazmi HR; Khare L; Srivastava M; Chandra A
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7069-7078. PubMed ID: 36871090
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of activation of a G protein-coupled receptor, the human cholecystokinin-2 receptor.
Marco E; Foucaud M; Langer I; Escrieut C; Tikhonova IG; Fourmy D
J Biol Chem; 2007 Sep; 282(39):28779-28790. PubMed ID: 17599907
[TBL] [Abstract][Full Text] [Related]
27. Sensitivity of cholecystokinin receptors to membrane cholesterol content.
Desai AJ; Miller LJ
Front Endocrinol (Lausanne); 2012; 3():123. PubMed ID: 23087674
[TBL] [Abstract][Full Text] [Related]
28. Different pathways mediated by CCK1 and CCK2 receptors: effect of intraperitonal mrna antisense oligodeoxynucleotides to cholecystokinin on anxiety-like and learning behaviors in rats.
Cohen H; Kaplan Z; Matar MA; Buriakovsky I; Bourin M; Kotler M
Depress Anxiety; 2004; 20(3):139-52. PubMed ID: 15487014
[TBL] [Abstract][Full Text] [Related]
29. CCK8 negatively regulates the TLR9-induced activation of human peripheral blood pDCs by targeting TRAF6 signaling.
Jia X; Cong B; Zhang J; Li H; Liu W; Chang H; Dong M; Ma C
Eur J Immunol; 2014 Feb; 44(2):489-99. PubMed ID: 24301797
[TBL] [Abstract][Full Text] [Related]
30. Membrane cholesterol in the function and organization of G-protein coupled receptors.
Paila YD; Chattopadhyay A
Subcell Biochem; 2010; 51():439-66. PubMed ID: 20213554
[TBL] [Abstract][Full Text] [Related]
31. The biologically crucial C terminus of cholecystokinin and the non-peptide agonist SR-146,131 share a common binding site in the human CCK1 receptor. Evidence for a crucial role of Met-121 in the activation process.
Escrieut C; Gigoux V; Archer E; Verrier S; Maigret B; Behrendt R; Moroder L; Bignon E; Silvente-Poirot S; Pradayrol L; Fourmy D
J Biol Chem; 2002 Mar; 277(9):7546-55. PubMed ID: 11724786
[TBL] [Abstract][Full Text] [Related]
32. Functional synergy between cholecystokinin receptors CCKAR and CCKBR in mammalian brain development.
Nishimura S; Bilgüvar K; Ishigame K; Sestan N; Günel M; Louvi A
PLoS One; 2015; 10(4):e0124295. PubMed ID: 25875176
[TBL] [Abstract][Full Text] [Related]
33. ANALYSIS OF INTERACTION OF PHENOLIC COMPOUNDS WITH CHOLECYSTOKININ SIGNALLING PATHWAY TO EXPLAIN EFFECTS ON REDUCING FOOD INTAKE.
Al Shukor N; Raes K; Van Camp J; Smagghe G
Commun Agric Appl Biol Sci; 2015; 80(1):177-82. PubMed ID: 26630774
[No Abstract] [Full Text] [Related]
34. Cholesterol interaction motifs in G protein-coupled receptors: Slippery hot spots?
Sarkar P; Chattopadhyay A
Wiley Interdiscip Rev Syst Biol Med; 2020 Jul; 12(4):e1481. PubMed ID: 32032482
[TBL] [Abstract][Full Text] [Related]
35. Progress in developing cholecystokinin (CCK)/gastrin receptor ligands that have therapeutic potential.
Berna MJ; Tapia JA; Sancho V; Jensen RT
Curr Opin Pharmacol; 2007 Dec; 7(6):583-92. PubMed ID: 17997137
[TBL] [Abstract][Full Text] [Related]
36. Characterization of a novel five-transmembrane domain cholecystokinin-2 receptor splice variant identified in human tumors.
Sanchez C; Escrieut C; Clerc P; Gigoux V; Waser B; Reubi JC; Fourmy D
Mol Cell Endocrinol; 2012 Feb; 349(2):170-9. PubMed ID: 22040601
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of modification of membrane cholesterol and sphingolipids on the conformation, function, and trafficking of the G protein-coupled cholecystokinin receptor.
Harikumar KG; Puri V; Singh RD; Hanada K; Pagano RE; Miller LJ
J Biol Chem; 2005 Jan; 280(3):2176-85. PubMed ID: 15537636
[TBL] [Abstract][Full Text] [Related]
38. CCK1 and 2 receptors are expressed in immortalized rat brain neuroblasts: intracellular signals after cholecystokinin stimulation.
Langmesser S; Cerezo-Guisado MI; Lorenzo MJ; Garcia-Marin LJ; Bragado MJ
J Cell Biochem; 2007 Mar; 100(4):851-64. PubMed ID: 17226751
[TBL] [Abstract][Full Text] [Related]
39. Genetic, pharmacological and functional analysis of cholecystokinin-1 and cholecystokinin-2 receptor polymorphism in type 2 diabetes and obese patients.
Marchal-Victorion S; Vionnet N; Escrieut C; Dematos F; Dina C; Dufresne M; Vaysse N; Pradayrol L; Froguel P; Fourmy D
Pharmacogenetics; 2002 Jan; 12(1):23-30. PubMed ID: 11773861
[TBL] [Abstract][Full Text] [Related]
40. Fluorescent indicators distributed throughout the pharmacophore of cholecystokinin provide insights into distinct modes of binding and activation of type A and B cholecystokinin receptors.
Harikumar KG; Pinon DI; Miller LJ
J Biol Chem; 2006 Sep; 281(37):27072-80. PubMed ID: 16857665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
